Imprimis Pharmaceuticals Announces Second Quarter 2018 Results
IMPRIMIS PHARMACEUTICALS (IMMY)
Last imprimis pharmaceuticals earnings: 5/10 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
imprimisrx.com
Company Research
Source: PR Newswire
SAN DIEGO, Aug. 6, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the second quarter 2018. Notable Highlights from the Second Quarter of 2018:Revenues of $10.4 million, up 51% year-over-year Gross ophthalmology-related revenue of $8.3 million, up 74% year-over-year Gross margin of 60% compared to 52% in second quarter 2017 Adjusted EBITDA (a non-GAAP measure) of $442,000 Operating activities produced positive cash flow of $1.4 million Net income (GAAP basis) of $2.5 million Cash balance increased for the second quarter 2018 compared to the first quarter 2018 17 straight quarters of double digit or better year-over-year revenue growth $21 million oversubscribed Series A investment into Surface Pharmaceuticals, a former subsidiary of Imprimis $5.3 million gain (below operating line) for deconsolidation of Surface Pharmaceuticals Launched Melt Pharmaceuticals, a new subsidiary, to develop and seek FDA approval for Impr
Show less
Read more
Impact Snapshot
Event Time:
IMMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMMY alerts
High impacting IMPRIMIS PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics